CLINICAL RESEARCH: CARDIAC IMAGING
Analysis of Regional Left Ventricular Function by Cineventriculography, Cardiac Magnetic Resonance Imaging, and Unenhanced and Contrast-Enhanced Echocardiography
A Multicenter Comparison of Methods
Rainer Hoffmann, MD*,*,
Stephan von Bardeleben, MD ,
Jaroslaw D. Kasprzak, MD ,
Adrian C. Borges, MD ,
Folkert ten Cate, MD||,
Christian Firschke, MD, FACC¶,
Stephane Lafitte, MD#,
Nidal Al-Saadi, MD**,
Stefanie Kuntz-Hehner, MD,
Georg Horstick, MD,
Christian Greis,
Marc Engelhardt, MD,
Jean Louis Vanoverschelde, MD, FACC|||| and
Harald Becher, MD¶¶
* University Rheinisch-Westfälischen Technischen Hochschule Aachen, Aachen, Germany
Clinic Johannes Gutenberg University Mainz, Mainz, Germany
Medical University, Lodz, Poland
University Charite, Berlin, Germany
|| Academic Hospital Dijkzigt Rotterdam, the Netherlands
¶ Deutsches Herzzentrum, Munich, Germany
# Hopital du Haut Leveque, Pessac Cedex, France
** University Charite, Berlin, Germany
University Bonn, Bonn, Germany
Bracco-Altana-Pharma, Konstanz, Germany
Bracco Diagnostics, Princeton, New Jersey
|||| Cliniques Universitaires Saint-Luc, Brussels, Belgium
¶¶ John Radcliffe Hospital, Oxford, United Kingdom
Manuscript received February 1, 2005;
revised manuscript received May 21, 2005,
accepted May 31, 2005.
* Reprint requests and correspondence: Dr. Rainer Hoffmann, Medical Clinic I, University RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
(Email: rhoffmann{at}ukaachen.de).
OBJECTIVES: To define the use of cineventriculography, cardiac magnetic resonance imaging (cMRI), and unenhanced and contrast-enhanced echocardiography for detection of left ventricular (LV) regional wall motion abnormalities (RWMA).
BACKGROUND: Detection of RWMA is integral to the evaluation of LV function.
METHODS: In 100 patients, cineventriculography and unenhanced and contrast-enhanced echocardiography were performed. Fifty-six of the patients underwent additional cMRI. RWMA were assessed referring to a 16-segment model for cMRI, unenhanced and contrast echocardiography. Cineventriculography was evaluated on a 7-segment model. Hypokinesia in one or more segments defined presence of RWMA. Interobserver agreement among three readers was determined within each imaging modality. Intermethod agreement between imaging modalities was analyzed. A standard of truth for the presence of RWMA was obtained by an independent expert panel decision (EPD) based on clinical data, electrocardiogram, coronary angiography, and blinded information from the imaging modalities.
RESULTS: Sixty-seven patients were found to have an RWMA by EPD. Interobserver agreement expressed as kappa coefficient was 0.41 (range 0.37 to 0.44) for unenhanced echocardiography, 0.43 (range 0.29 to 0.79) for cMRT, 0.56 (range 0.44 to 0.70) for cineventriculography, and 0.77 (range 0.71 to 0.88) for contrast echocardiography. Contrast enhancement compared to unenhanced echocardiography improved agreement of echocardiography related to cMRI (kappa 0.46 vs. 0.29) and related to cineventriculography (kappa 0.59 vs. 0.28). Accuracy to detect EPD-defined RWMA was highest for contrast echocardiography, followed by cMRI, unenhanced echocardiography, and cineventriculography.
CONCLUSIONS: Analysis of RWMA is characterized by considerable interobserver variability even using high-quality imaging modalities. Interobserver agreement on RWMA and accuracy to detect panel-defined RWMA is good using contrast echocardiography.
|
Abbreviations and Acronyms
| | cMRI = cardiac magnetic resonance imaging | | ECG = electrocardiogram | | EPD = expert panel decision | | IOA = interobserver agreement | | LV = left ventricle/ventricular | | RWMA = regional wall motion abnormality | | OffR = off-site reader | | OnR = on-site reader |
|
This article has been cited by other articles:
|
|
|
|
 
B. Cosyns, G. Van Camp, S. Droogmans, C. Weytjens, D. Schoors, and P. Lancellotti
Analysis of regional wall motion during contrast-enhanced dobutamine stress echocardiography: effect of contrast imaging settings
Eur J Echocardiogr,
December 1, 2009;
10(8):
956 - 960.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Lockie, E. Nagel, S. Redwood, and S. Plein
Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes
Circulation,
March 31, 2009;
119(12):
1671 - 1681.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Jenkins, S. Moir, J. Chan, D. Rakhit, B. Haluska, and T. H. Marwick
Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging
Eur. Heart J.,
January 1, 2009;
30(1):
98 - 106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Nucifora, N. A. Marsan, H.-M. J. Siebelink, J. M. van Werkhoven, J. D. Schuijf, M. J. Schalij, D. Poldermans, E. R. Holman, and J. J. Bax
Safety of contrast-enhanced echocardiography within 24 h after acute myocardial infarction
Eur J Echocardiogr,
November 1, 2008;
9(6):
816 - 818.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H. Marwick and M. Schwaiger
The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools
Circ Cardiovasc Imaging,
July 1, 2008;
1(1):
58 - 69.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Hoffmann, A. C. Borges, J. D. Kasprzak, S. von Bardeleben, C. Firschke, C. Greis, M. Engelhardt, H. Becher, and J. L. Vanoverschelde
Analysis of myocardial perfusion or myocardial function for detection of regional myocardial abnormalities. An echocardiographic multicenter comparison study using myocardial contrast echocardiography and 2D echocardiography
Eur J Echocardiogr,
December 1, 2007;
8(6):
438 - 448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Olszewski, J. Timperley, S. Cezary, M. Monaghan, P. Nihoyannopoulis, R. Senior, and H. Becher
The clinical applications of contrast echocardiography
Eur J Echocardiogr,
June 1, 2007;
8(3):
s13 - s23.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Jaochim Nesser, L. Sugeng, C. Corsi, L. Weinert, J. Niel, C. Ebner, R. Steringer-Mascherbauer, F. Schmidt, G. Schummers, R. M Lang, et al.
Volumetric analysis of regional left ventricular function with real-time three-dimensional echocardiography: validation by magnetic resonance and clinical utility testing
Heart,
May 1, 2007;
93(5):
572 - 578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al.
Highlights of the Year in JACC 2006
J. Am. Coll. Cardiol.,
January 30, 2007;
49(4):
509 - 527.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Hoffmann
The demystification of magnetic resonance imaging?
Eur. Heart J.,
June 2, 2006;
27(12):
1394 - 1395.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. F. Bolger
Do You See What I See?: Agreeing to Disagree
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
129 - 130.
[Full Text]
[PDF]
|
|
|
|
